Skip to content
Saturday, May 31, 2025
Latest:
  • Renewing hope: A global push to improve neonatal outcomes
  • FROM THE LABS: Cell Painting identifies flavonoids that are toxic to bladder cancer cells
  • Menopause 101
  • New technique offers lasting relief for slipping rib syndrome
  • Ready for space travel? GENESTAR can track how space affects your health
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
Policywise

Probiotics and preemies: Ensuring safety amid uncertainty

October 11, 2024 Dietary supplements,  FDA,  necrotizing enterocolitis,  neonatology,  NICU,  pediatrics,  probiotics,  Regulation

As a neonatologist dedicated to the care of premature infants, I constantly navigate the delicate balance between innovation and caution in the treatments we offer.

Read More
Policywise

Inaccurate oxygen readings: the problem with pulse oximeters

August 19, 2022 Biases,  FDA,  inaccuracy,  oxygen,  policy,  Pulse oximeters,  racial and ethnic minority patients,  regulatory requirements

Pulse oximeters are medical devices that measure how much oxygen is available in the body. This measurement, called the oxygen saturation, is a vital sign

Read More
Policywise

Dietary supplements, vitamin A, and regulation: a call to action

June 17, 2022 Accutane,  Dietary supplements,  FDA,  regulations,  supplements,  Teratogenic risks,  Vitamin A,  Vitamin A supplements

Dietary supplements in the United States are considered foods by the U.S. Food and Drug Administration, and thus they are not subject to the same

Read More
Policywise

The gene therapy watchers: Can an NIH advisory committee reinvent itself?

October 5, 2018 Center for Medical Ethics and Health Policy,  Dr. Christopher Scott,  FDA,  gene therapy,  NIH

Francis Collins, NIH Director, and Scott Gottlieb, FDA Commissioner, recently announced plans to eliminate oversight of new gene therapy experiments by the NIH’s Recombinant DNA

Read More
Policywise

Vaping: A new epidemic among our youth

September 21, 2018 Dr. Amy McGuire,  E-Cigarettes,  FDA,  Tobacco,  Vaping

A few years ago I found what looked like a flash drive plugged into the wall in my teenage son’s room. I took it and

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951